The North America Artificial Intelligence In Precision Medicine Market should witness market growth of 31.7% CAGR during the forecast period (2022-2028).
The market is growing as a consequence of increased elderly populations, rapid technological breakthroughs in healthcare, and rising respiratory illness rates. The sector will rise in part due to the rising popularity of therapeutic respiratory devices such as oxygen concentrators, nebulizers, and humidifiers.
The respiratory segment is anticipated to develop as respiratory conditions, including sleep apnea and chronic obstructive pulmonary disease, become more common. 3.23 million people worldwide will pass away in 2019 from moderate and severe chronic obstructive pulmonary diseases, according to WHO forecasts (COPD).
Major corporations are using partnerships and collaborations more frequently as a means of preserving their market position. For instance, Intel and the Perelman School of Medicine at the University of Pennsylvania worked together to develop an AI model that aids in the early diagnosis of brain tumors.
Demand for the market in the United States is anticipated to be driven by the high adoption rate of AI technologies throughout healthcare and pharma, the substantial presence of leading AI software and system suppliers, and the merged investment by government and private organizations in the improvement and growth of research and development activities. The nation's strong infrastructure, which can accommodate cutting-edge medical solutions, is likely to help it eventually take the lead in the regional market.
The US market dominated the North America Artificial Intelligence in Precision Medicine Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1, 549.5 Million by 2028.The Canada market is poised to grow at a CAGR of 34.7% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 33.5% during (2022-2028).
Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Respiratory and Others. Based on Component, the market is segmented into Software, Hardware and Service. Based on Technology, the market is segmented into Deep Learning, Natural Language Processing, Querying Method and Context Aware Processing. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Sanofi S.A., NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Google LLC (Alphabet Inc.), AstraZeneca PLC, and Tempus, Inc.
The market is growing as a consequence of increased elderly populations, rapid technological breakthroughs in healthcare, and rising respiratory illness rates. The sector will rise in part due to the rising popularity of therapeutic respiratory devices such as oxygen concentrators, nebulizers, and humidifiers.
The respiratory segment is anticipated to develop as respiratory conditions, including sleep apnea and chronic obstructive pulmonary disease, become more common. 3.23 million people worldwide will pass away in 2019 from moderate and severe chronic obstructive pulmonary diseases, according to WHO forecasts (COPD).
Major corporations are using partnerships and collaborations more frequently as a means of preserving their market position. For instance, Intel and the Perelman School of Medicine at the University of Pennsylvania worked together to develop an AI model that aids in the early diagnosis of brain tumors.
Demand for the market in the United States is anticipated to be driven by the high adoption rate of AI technologies throughout healthcare and pharma, the substantial presence of leading AI software and system suppliers, and the merged investment by government and private organizations in the improvement and growth of research and development activities. The nation's strong infrastructure, which can accommodate cutting-edge medical solutions, is likely to help it eventually take the lead in the regional market.
The US market dominated the North America Artificial Intelligence in Precision Medicine Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1, 549.5 Million by 2028.The Canada market is poised to grow at a CAGR of 34.7% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 33.5% during (2022-2028).
Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Respiratory and Others. Based on Component, the market is segmented into Software, Hardware and Service. Based on Technology, the market is segmented into Deep Learning, Natural Language Processing, Querying Method and Context Aware Processing. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Sanofi S.A., NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Google LLC (Alphabet Inc.), AstraZeneca PLC, and Tempus, Inc.
Scope of the Study
By Application
- Oncology
- Cardiology
- Neurology
- Respiratory
- Others
By Component
- Software
- Hardware
- Service
By Technology
- Deep Learning
- Natural Language Processing
- Querying Method
- Context Aware Processing
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- Sanofi S.A.
- NVIDIA Corporation
- Intel Corporation
- Microsoft Corporation
- IBM Corporation
- Google LLC (Alphabet Inc.)
- AstraZeneca PLC
- Tempus, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Artificial Intelligence in precision Medicine Market, by Application
1.4.2 North America Artificial Intelligence in precision Medicine Market, by Component
1.4.3 North America Artificial Intelligence in precision Medicine Market, by Technology
1.4.4 North America Artificial Intelligence in precision Medicine Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.3 Market Share Analysis, 2021
3.4 Top Winning Strategies
3.4.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.4.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Jan - 2022, Nov) Leading Players
Chapter 4. North America Artificial Intelligence in Precision Medicine Market by Application
4.1 North America Oncology Market by Country
4.2 North America Cardiology Market by Country
4.3 North America Neurology Market by Country
4.4 North America Respiratory Market by Country
4.5 North America Others Market by Country
Chapter 5. North America Artificial Intelligence in Precision Medicine Market by Component
5.1 North America Software Market by Country
5.2 North America Hardware Market by Country
5.3 North America Service Market by Country
Chapter 6. North America Artificial Intelligence in Precision Medicine Market by Technology
6.1 North America Deep Learning Market by Country
6.2 North America Natural Language Processing Market by Country
6.3 North America Querying Method Market by Country
6.4 North America Context Aware Processing Market by Country
Chapter 7. North America Artificial Intelligence in Precision Medicine Market by Country
7.1 US Artificial Intelligence in Precision Medicine Market
7.1.1 US Artificial Intelligence in Precision Medicine Market by Application
7.1.2 US Artificial Intelligence in Precision Medicine Market by Component
7.1.3 US Artificial Intelligence in Precision Medicine Market by Technology
7.2 Canada Artificial Intelligence in Precision Medicine Market
7.2.1 Canada Artificial Intelligence in Precision Medicine Market by Application
7.2.2 Canada Artificial Intelligence in Precision Medicine Market by Component
7.2.3 Canada Artificial Intelligence in Precision Medicine Market by Technology
7.3 Mexico Artificial Intelligence in Precision Medicine Market
7.3.1 Mexico Artificial Intelligence in Precision Medicine Market by Application
7.3.2 Mexico Artificial Intelligence in Precision Medicine Market by Component
7.3.3 Mexico Artificial Intelligence in Precision Medicine Market by Technology
7.4 Rest of North America Artificial Intelligence in Precision Medicine Market
7.4.1 Rest of North America Artificial Intelligence in Precision Medicine Market by Application
7.4.2 Rest of North America Artificial Intelligence in Precision Medicine Market by Component
7.4.3 Rest of North America Artificial Intelligence in Precision Medicine Market by Technology
Chapter 8. Company Profiles
8.1 General Electric (GE) Co. (GE Healthcare)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.6 SWOT Analysis
8.2 Google LLC (Alphabet Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Intel Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Microsoft Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 IBM Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 NVIDIA Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.6 SWOT Analysis
8.7 AstraZeneca PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Tempus, Inc.
8.9.1 Company Overview
Companies Mentioned
- General Electric (GE) Co. (GE Healthcare)
- Sanofi S.A.
- NVIDIA Corporation
- Intel Corporation
- Microsoft Corporation
- IBM Corporation
- Google LLC (Alphabet Inc.)
- AstraZeneca PLC
- Tempus, Inc.
Methodology
LOADING...
